Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Velvet/Oases transcript expression level?

    Hi,
    I am in the process of de novo transcriptome assembly from a non-model eukaryote. I have 17 million 65 bp, paired-end reads that I have assembled with Velvet and then Oases. This gives nice results in that I am getting full-length contigs that appear reasonable when compared to orthologues in related model eukaryotes. However, I am really after relative transcript expression levels. Does anyone know if there as a way that I can get information on that from this software combination?

  • #2
    Hi Simon,

    I'm not by any means an expert on this, but you probably have two options:

    1. Convert the kmer coverage in the stats.txt file to base-coverage and use that as a proxy for expression level

    2. Align the reads to the assembled transcripts using something like Bowtie and then extract the coverage of each transcript using SAMTools

    Hope that helps!

    Comment


    • #3
      Velvet question

      How can one extract all of the reads that were used in the assembly, in order to do the re-mapping step you described?

      Comment


      • #4
        Under the contrib/extractContigReads directory in Velvet you'll find a script to do this

        Comment

        Latest Articles

        Collapse

        • seqadmin
          Understanding Genetic Influence on Infectious Disease
          by seqadmin




          During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

          Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
          09-09-2024, 10:59 AM
        • seqadmin
          Addressing Off-Target Effects in CRISPR Technologies
          by seqadmin






          The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
          08-27-2024, 04:44 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by seqadmin, Yesterday, 02:44 PM
        0 responses
        8 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-06-2024, 08:02 AM
        0 responses
        145 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 09-03-2024, 08:30 AM
        0 responses
        152 views
        0 likes
        Last Post seqadmin  
        Started by seqadmin, 08-27-2024, 04:40 AM
        0 responses
        159 views
        0 likes
        Last Post seqadmin  
        Working...
        X